145 related articles for article (PubMed ID: 19236423)
1. Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell lymphoma.
Miyagaki T; Sugaya M; Fujita H; Saeki H; Tamaki K
Clin Exp Dermatol; 2009 Jun; 34(4):539-40. PubMed ID: 19236423
[No Abstract] [Full Text] [Related]
2. Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Suga H; Morimura S; Miyagaki T; Kai H; Kagami S; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2012 May; 92(3):282-3. PubMed ID: 22456907
[No Abstract] [Full Text] [Related]
3. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
4. Increased serum neopterin levels in mycosis fungoides and Sézary syndrome.
Hamerlinck FF; Toonstra J; van Vloten WA
Br J Dermatol; 1999 Dec; 141(6):1136-7. PubMed ID: 10722267
[No Abstract] [Full Text] [Related]
5. Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Kagami S; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2013 Mar; 93(2):144-9. PubMed ID: 22948508
[TBL] [Abstract][Full Text] [Related]
6. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.
Oka T; Miyagaki T; Takahashi N; Nakajima R; Kamijo H; Suga H; Asano Y; Sugaya M; Sato S
J Invest Dermatol; 2018 Oct; 138(10):2286-2288. PubMed ID: 29605670
[No Abstract] [Full Text] [Related]
7. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
8. Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome.
Sakamoto M; Miyagaki T; Kamijo H; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
J Dermatol; 2018 Jan; 45(1):95-99. PubMed ID: 28925057
[TBL] [Abstract][Full Text] [Related]
9. Expression of Sézary Biomarkers in the Blood of Patients with Erythrodermic Mycosis Fungoides.
Hurabielle C; Michel L; Ram-Wolff C; Battistella M; Jean-Louis F; Beylot-Barry M; d'Incan M; Bensussan A; Bagot M
J Invest Dermatol; 2016 Jan; 136(1):317-20. PubMed ID: 26763453
[No Abstract] [Full Text] [Related]
10. CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis.
Sugaya M; Morimura S; Suga H; Kawaguchi M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
J Dermatol; 2015 Jun; 42(6):613-5. PubMed ID: 25809616
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
[TBL] [Abstract][Full Text] [Related]
12. CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16.
Tuzova M; Richmond J; Wolpowitz D; Curiel-Lewandrowski C; Chaney K; Kupper T; Cruikshank W
Leuk Lymphoma; 2015 Feb; 56(2):440-9. PubMed ID: 24794807
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.
Bernengo MG; Fierro MT; Novelli M; Lisa F; Appino A
Br J Dermatol; 1993 Feb; 128(2):124-9. PubMed ID: 8457444
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Serum Copper in Patients With Cutaneous T-cell Lymphoma.
Vonderheid EC; Martinez AR
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):228-238.e4. PubMed ID: 30745139
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
16. Increased Serum Activin A Levels in Mycosis Fungoides and Sézary Syndrome.
Oka T; Miyagaki T; Kamijo H; Nakajima R; Shishido-Takahashi N; Senda N; Suga H; Sugaya M; Sato S
Acta Derm Venereol; 2019 Oct; 99(11):1039-1040. PubMed ID: 31240323
[No Abstract] [Full Text] [Related]
17. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
Möbs M; Gryzik S; Haidar A; Humme D; Beyer M; Vandersee S
Arch Dermatol Res; 2015 Aug; 307(6):479-85. PubMed ID: 25488078
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
[TBL] [Abstract][Full Text] [Related]
20. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
